Atlas Trials

Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

Clinical trial NCT00241462 · TERMINATED

Trial details

NCT number
NCT00241462
Sponsor
AstraZeneca
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2005-06-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.